Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- VIRTUOSO SURGICAL, INC.
- Proposal award date
- 2019-08-05
- Contract end date
- 2021-07-30
- UEI
- GERAVN61UL56
- Solicitation number
- PA18-574
- Topic code
- NHLBI
Research abstract
Project Summary/Abstract:
The objective of this proposal is to create a new surgical device that provides dexterity at the tip of a rigid
bronchoscope. Our new system will deliver needle-sized, tentacle-like arms through the bronchoscope port,
enabling independent tissue manipulation, laser fiber aiming, and visualization, which we hypothesize will make
central airway obstruction surgery safer, more effective, and more efficient.
Clinical significance comes from the large number of patients affected by central airway obstruction – There are
over 80,000 new diagnoses per year in the USA alone [13, 15] – as well as the severity for individual patients,
since lack of an adequate airway is fatal. Existing surgical approaches are challenging because instruments
deployed through rigid bronchoscope ports lack lateral dexterity, and can only be aimed by tilting the entire
bronchoscope, which applies large forces on the patientandapos;s neck and teeth. Consequently, 32% of patients have
complications including broken teeth, cervical spine injury, hemorrhage, and even death.
Innovation comes from using elastic interactions of curved tubes to create miniature manipulators that can bend
and elongate. These manipulators are small enough to pass through the port in an existing clinical bronchoscope
to provide tentacle-like dexterity at its tip, and are an order of magnitude smaller than current commercial surgical
robot manipulators. The system we propose will also be the first robotic system designed for central airway
obstruction surgery. And because it has dramatically fewer mechanical and electronic components than current
commercial surgical robots, our end product has the potential to be an order of magnitude less expensive, while
still providing a healthy revenue stream and profit margin for our company.
Our approach in Aim 1 is to design a manufacturable, operating-room-ready robotic system including actuation
components and modular, disposable instruments, and to complete FDA biocompatibility testing. Aim 2 focuses
on the user interface control mappings and validation through the FDA human factors testing process. In Aim 3,
we validate the entire system experimentally, quantitatively comparing surgeon performance with our robotic
system to the current standard of care. The outcomes of this project are (1) an operating-room-ready robotic
system, (2) completion of the FDA biocompatibility and human factors testing needed for 510(k) approval, and
(3) the collection of quantitative experimental data in cadavers demonstrating that our system makes central
airway obstruction surgery safer, more effective, and more efficient.Narrative: Public Health Relevance
Over 80,000 new patients each year are diagnosed with central airway obstruction in the USA alone, and cur-
rent surgical approaches are invasive, with approximately 1/3 of patients suffering complications including neck
injury, hemorrhage, and even death, due to lack of instrument dexterity. We propose to create new miniature
tentacle-like instruments that will enable the surgeon to dexterously manipulate surgical tools in the central air-
way endoscopically. This system promises to increase the safety, effectiveness, and efficiency of surgery, and
reduce complication rates for patients with central airway obstructions.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
4 SBIR/STTR records share this UEI (2017–2023). Reported award amounts total $5,179,607. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards